Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is currently in a long term downtrend where the price is trading 2.3% below its 200 day moving average.

From a valuation standpoint, the stock is 66.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.2.

Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd's total revenue rose by 22.2% to $214M since the same quarter in the previous year.

Its net income has increased by 144.6% to $34M since the same quarter in the previous year.

Finally, its free cash flow grew by 136.9% to $23M since the same quarter in the previous year.

Based on the above factors, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd gets an overall score of 4/5.